ConductScience.org, home
A Study of VAL401 in the Treatment of Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer
API referenceFor AI assistants

Trial · NCT02875340

Results by group66

Each measurement the trial posted, group by group, in the words and numbers it posted.

1 to 20 of 66

Download this page as JSON
OutcomeGroupCategoryValueSpreadUnits
Progression-free Survival (PFS)VAL401 Treatment - Intention to Treat Group5.2Full Range 0.4 to 11.6weeks
Progression-free Survival (PFS)VAL401 Treatment - Per Protocol Group7.2Full Range 4.0 to 11.6weeks
Patient Quality of Life During VAL401 TreatmentVAL401 TreatmentECOG data / Not measured4Participants
Patient Quality of Life During VAL401 TreatmentVAL401 TreatmentECOG data / Status maintained3Participants
Patient Quality of Life During VAL401 TreatmentVAL401 TreatmentECOG data / Status deteriorated1Participants
Patient Quality of Life During VAL401 TreatmentVAL401 TreatmentECOG data / Status improved0Participants
Patient Quality of Life During VAL401 TreatmentVAL401 TreatmentImprovement in pain / Not measured2Participants
Patient Quality of Life During VAL401 TreatmentVAL401 TreatmentImprovement in pain / Status maintained2Participants
Patient Quality of Life During VAL401 TreatmentVAL401 TreatmentImprovement in pain / Status deteriorated0Participants
Patient Quality of Life During VAL401 TreatmentVAL401 TreatmentImprovement in pain / Status improved4Participants
Patient Quality of Life During VAL401 TreatmentVAL401 TreatmentImprovement in Insomnia / Not measured2Participants
Patient Quality of Life During VAL401 TreatmentVAL401 TreatmentImprovement in Insomnia / Status maintained3Participants
Patient Quality of Life During VAL401 TreatmentVAL401 TreatmentImprovement in Insomnia / Status deteriorated1Participants
Patient Quality of Life During VAL401 TreatmentVAL401 TreatmentImprovement in Insomnia / Status improved2Participants
Patient Quality of Life During VAL401 TreatmentVAL401 TreatmentImprovement in lack of appetite / Not measured2Participants
Patient Quality of Life During VAL401 TreatmentVAL401 TreatmentImprovement in lack of appetite / Status maintained3Participants
Patient Quality of Life During VAL401 TreatmentVAL401 TreatmentImprovement in lack of appetite / Status deteriorated1Participants
Patient Quality of Life During VAL401 TreatmentVAL401 TreatmentImprovement in lack of appetite / Status improved2Participants
Patient Quality of Life During VAL401 TreatmentVAL401 TreatmentImprovement in nausea/vomiting / Not measured2Participants
Patient Quality of Life During VAL401 TreatmentVAL401 TreatmentImprovement in nausea/vomiting / Status maintained4Participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02875340/results

API referenceFor AI assistants